Iovance Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iovance Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iovance Bio Today - Breaking & Trending Today

BNT211 With or Without CARVac Shows Early Activity in CLDN6+ R/R Advanced Solid Tumors

Published: November 5, 2023

The Claudin-6–directed CAR T-cell therapy, BNT211, showed signs of clinical activity in patients with CLDN6-positive relapsed or refractory solid tumors.

Source: onclive.com

Related Topics:

Roche GenentechMerck SeronoIovance BioAsher BioTranslational Immunotherapy Of Cancer At Leiden UniversityBristol Myers SquibbLeiden UniversityInstil BioMolecular PartnersNeogene TherapeuticsThird Rock VenturesSastra CellCarvac Solid TumorsCart Cell TherapyBnt211 01 Trial